14P - Case-control study: smoking history affects the production of tumor antigen specific antibodies in patients with NSCLC in comparison with cancer dis...

Date 28 March 2014
Event ELCC 2014
Session Lunch and poster display session
Topics Cancer Aetiology, Epidemiology, Prevention
Lung and other Thoracic Tumours
Translational Research
Presenter Dagmar Myšíková
Citation Journal of Thoracic Oncology (2014) 9 (Supplement 9): S7-S52. 10.1097/JTO.0000000000000131
Authors D. Myšíková1, J. Šimonek1, J. Pozniak1, J. Kolařík1, R. Špíšek2, R. Lischke1
  • 1Thoracic And Lung Transplantation Division, 3rd Department Of Surgery, First Faculty of Medicine,Charles University in Prague and University Hospital Motol, 15006 - Prague/CZ
  • 2Department Of Immunology, Second Faculty of Medicine,Charles University in Prague and University Hospital Motol, 15006 - Prague/CZ

Abstract

We focused on an impact of active smoking in a prospective case-control study comparing differences in the frequency of tumor antigen specific antibodies (TAA) in the serum in the group of NSCLC patients versus benign diagnosis group.